TBIS 01% MENT (Tacrolimus (0.1% w/w))

TBIS 0.1% Ointment is indicated for the management of eczema, also referred to as atopic dermatitis. Its therapeutic action is based on the inhibition of specific immune cells responsible for the inflammatory response, which includes symptoms such as redness and swelling of the skin. By reducing these inflammatory processes, the ointment alleviates discomfort associated with itching and aids in the improvement of rashes commonly seen in cases of atopic dermatitis. This formulation is intended solely for external application. The recommended frequency of use is 2 to 4 times daily, or as directed by a healthcare professional. For effective application, the ointment should be spread evenly over the affected area and gently massaged into the skin until fully absorbed. It is important to avoid excessive use and refrain from covering the treated region with any dressings or bandages. If there is no noticeable improvement in symptoms after two weeks of consistent use or if the condition appears to worsen, it is crucial to consult with a healthcare provider. While this ointment may lead to some mild adverse effects such as erythema, headaches, inflammation of hair follicles, and local application site reactions like burning, itching, and redness, it is typically not advised for use during pregnancy or lactation unless absolutely necessary.